A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis

British Journal of Pharmacology
166 (2), pp 737-748

J. Kankanala, A.M. Latham, A.P. Johnson, S. Homer-Vanniasinkam, C.W.G. Fishwick, S. Ponnambala

Get in touch

You need a high-performing, reliable and easy-to-use software solution to speed up your next big scientific breakthrough. Getting the right solution is integral to advance your research and workflow.